Your browser doesn't support javascript.
loading
The MUK five protocol: a phase II randomised, controlled, parallel group, multi-centre trial of carfilzomib, cyclophosphamide and dexamethasone (CCD) vs. cyclophosphamide, bortezomib (Velcade) and dexamethasone (CVD) for first relapse and primary refractory multiple myeloma.
Brown, Sarah; Hinsley, Samantha; Ballesteros, Mónica; Bourne, Sue; McGarry, Paul; Sherratt, Debbie; Flanagan, Louise; Gregory, Walter; Cavenagh, Jamie; Owen, Roger; Williams, Cathy; Kaiser, Martin; Low, Eric; Yong, Kwee.
Afiliação
  • Brown S; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • Hinsley S; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • Ballesteros M; Methodology of Biomedical Research and Public Health Programme, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Bourne S; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • McGarry P; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • Sherratt D; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • Flanagan L; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • Gregory W; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • Cavenagh J; Department of Haematology, St Bartholomew's Hospital, London, UK.
  • Owen R; HMDS Laboratory, St James's University Hospital, Leeds, UK.
  • Williams C; Centre for Clinical Haematology, Nottingham University Hospitals, Nottingham, UK.
  • Kaiser M; The Institute of Cancer Research, Sutton, UK.
  • Low E; Myeloma UK, Edinburgh, UK.
  • Yong K; UCL Cancer Institute, 72 Huntley Street, WC1E 6BT London, UK.
BMC Hematol ; 16: 14, 2016.
Article em En | MEDLINE | ID: mdl-27190631

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: BMC Hematol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: BMC Hematol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Reino Unido